Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Ependymoma × Azacitidine × Clear all

Phase

Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Radiotherapy 2 Methotrexate 2 fluorodopa F 18 1 etoposide phosphate 1 Temozolomide 1 Radiation 1 Perfusion Magnetic Resonance Imaging 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gadolinium DTPA 1 Etoposide 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Diffusion Magnetic Resonance Imaging 1 Biopsy 1 Azacitidine 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡